Laboratory diagnosis of invasive candidiasis

Journal of Microbiology

Volumn 43, Issue , 2005, Pages 65-84

  Ellepola, Arjuna N B ^a,b   Morrison, Christine J ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF PERADENIYA   (Sri Lanka)

Author keywords

Candida; Candidiasis; Diagnosis; Laboratory tests

Indexed keywords

ANTIFUNGAL AGENT; ARABINITOL; FUNGUS ANTIBODY; FUNGUS ANTIGEN; GLUCAN;

ANTIBIOTIC SENSITIVITY; ANTIBODY DETECTION; ANTIGEN DETECTION; AUTOPSY; BLOOD CULTURE; CANDIDA; CANDIDIASIS; CLINICAL LABORATORY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; DISEASE COURSE; DNA POLYMORPHISM; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE IN SITU HYBRIDIZATION; FUNGAL VIRULENCE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; MEDICAL RESEARCH; MICROBIOLOGY; MOLECULAR BIOLOGY; MORBIDITY; MORTALITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; SYMPTOMATOLOGY; URINE CULTURE; VALIDATION PROCESS;

BLOOD; CANDIDA; CANDIDIASIS; CULTURE MEDIA; DNA, FUNGAL; FUNGEMIA; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MYCOLOGICAL TYPING TECHNIQUES; POLYMERASE CHAIN REACTION;

EID: 15944379521     PISSN: 12258873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (178)

1. Abi-Said, D., E. Anaissie, O. Uzun, I. Raad, H. Pinzcowski, and S. Vartivarian. 1997. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis. 24, 1122-1128. Erratum in: Clin. Infect. Dis. 25, 352.
2. Al Mosaid, A., J. Sullivan, and D.C. Coleman. 2003. Differentiation of Candida dubliniensis from Candida albicans on Pal's agar. J Clin. Microbiol. 41, 4787-4789.
3. Araj, G.F., R.L. Hopfer, S. Chesnut, V. Fainstein, and G.P. Bodey GP. 1982. Diagnostic value of the enzyme-linked immunosorbent assay for detection of Candida albicans cytoplasmic antigen in sera of cancer patients. J Clin. Microbiol. 16, 46-52.
4. Archibald, L.K., L.C. McDonald, R.M. Addison, C. McKnight, T. Byrne, H. Dobbie, O. Nwanyanwu, P. Kazembe, L.B. Reller, and W.R. Jarvis. 2000. Comparison of BACTEC MYCO/F Lytic and WAMPOLE ISOLATOR 10 (lysis-centrifugation) systems for detection of bacteremia, mycobacteremia, and fungemia in a developing country. J Clin. Microbiol. 38, 2994-2997.
5. Bailey, J.W., E. Sada, C. Brass, and J.E. Bennett. 1985. Diagnosis of systemic candidiasis by latex agglutination for serum antigen. J Clin. Microbiol. 21, 749-752.
6. Banerjee, S.N., T.G. Emori, D.H. Culver, R.P. Gaynes, W.R. Jarvis, T. Horan, J.R. Edwards, J. Tolson, T. Henderson, and W.J. Martone. 1991. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am. J Med. 91, 86S-89S.
7. Bar, W., and H. Hecker. 2002. Diagnosis of systemic Candida infections in patients of the intensive care unit. Significance of serum antigens and antibodies. Mycoses. 45, 22-28.
8. Baumgartner, C., A.M. Freydiere, and Y. Gille. 1996. Direct identification and recognition of yeast species from clinical material by using Albicans ID and CHROMagar Candida plates. J Clin. Microbiol. 34, 454-456.
9. Bautista-Munoz, C., X.M. Boldo, L. Villa-Tanaca, and C. Hernandez-Rodriguez. 2003. Identification of Candida spp. by randomly amplified polymorphic DNA analysis and differentiation between Candida albicans and Candida dubliniensis by direct PCR methods. J Clin. Microbiol. 41, 414-420.
10. Berenguer, J., M. Buck, F. Witebsky, F. Stock, P.A. Pizzo, and T.J. Walsh. 1993. Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Diagn. Microbiol. Infect. Dis. 17, 103-109.
11. Bernal, S., E. Martin Mazuelos, M. Chavez, J. Coronilla, and A. Valverde. 1998. Evaluation of the new API Candida system for identification of the most clinically important yeast species. Diagn. Microbiol. Infect. Dis. 32, 217-221.
12. Bikandi, J., R.S. Millan, M.D. Moragues, G. Cebas, M. Clarke, D.C. Coleman, D.J. Sullivan, G. Quindos, and J. Ponton. 1998. Rapid identification of Candida dubliniensis by indirect immunofluorescence based on differential localization of antigens on C. dubliniensis blastospores and Candida albicans germ tubes. J Clin. Microbiol. 36, 2428-2433.
13. Borst, A., B. Theelen, E. Reinders, T. Boekhout, A.C. Fluit, and P.H. Savelkoul. 2003. Use of amplified fragment length polymorphism analysis to identify medically important Candida spp., including C. dubliniensis. J Clin. Microbiol. 41, 1357-1362.
14. Boucher, H., S. Mercure, S. Montplaisir, and G. Lemay. 1996. A novel group I intron in Candida dubliniensis is homologous to a Candida albicans intron. Gene. 180, 189-196.
15. Bougnoux, M.E., C. Hill, D. Moissenet, M. Feuilhade de Chauvin, M. Bonnay, I. Vicens-Sprauel, F. Pietri, M. McNeil, L. Kaufman, and J. Dupouy-Camet. 1990. Comparison of antibody, antigen, and metabolite assays for hospitalized patients with disseminated or peripheral candidiasis. J Clin. Microbiol. 28, 905-909.
16. Buchman, T.G., M. Rossier, W.G. Merz, and P. Charache. 1990. Detection of surgical pathogens by in vitro DNA amplification. Part I. Rapid identification of Candida albicans by in vitro amplification of a fungus-specific gene. Surgery. 108, 338-347.
17. Burgener-Kairuz, P., J.P. Zuber, P. Jaunin, T.G. Buchman, J. Bille, and M. Rossier. 1994. Rapid detection and identification of Candida albicans and Torulopsis (Candida) glabrata in clinical specimens by species-specific nested PCR amplification of a cytochrome P-450 lanosterol-a-demethylase (L1A1) gene fragment. J Clin. Microbiol. 32, 1902-1907.
18. Burnie, J.P. 1985. A reverse passive latex agglutination test for the diagnosis of systemic candidiasis. J Immunol. Methods. 82, 267-280.
19. Campbell, C.K., K.G. Davey, A.D. Holmes, A. Szekely, and D.W. Warnock. 1999. Comparison of the API Candida system with the AUXACOLOR system for identification of common yeast pathogens. J Clin. Microbiol. 37, 821-823.
20. Centers for Disease Control and Prevention. 2000. Monitoring hospital acquired infections to promote patient safety in the United States, 1990-1999. Morb. Mortal Wkly Rep. 49, 149-153.
21. Chen, Y.C., J.D. Eisner, M.M. Kattar, S.L. Rassoulian-Barrett, K. LaFe, S.L. Yarfitz, A.P. Limaye, and B.T. Cookson. 2000. Identification of medically important yeasts using PCR-based detection of DNA sequence polymorphisms in the internal transcribed spacer 2 region of the rRNA genes. J Clin. Microbiol. 38, 2302-2310.
22. Christensson, B., G. Sigmundsdottir, and L. Larsson. 1999. D-arabinitol - a marker for invasive candidiasis. Med. Mycol. 37, 391-396.
23. Cirak, M.Y., A. Kalkanci, and S. Kustimur. 2003. Use of molecular methods in identification of Candida species and evaluation of fluconazole resistance. Mem. Inst. Oswaldo. Cruz. 98, 1027-1032.
24. Coignard, C., S.F. Hurst, L.E. Benjamin, M.E. Brandt, D.W. Warnock, and C.J. Morrison. 2004. Resolution of discrepant results for Candida species identification by using DNA probes. J Clin. Microbiol. 42, 858-861.
25. Crampin, A.C. and R.C. Matthews. 1993. Application of the polymerase chain reaction to the diagnosis of candidosis by amplification of an HSP 90 gene fragment. J Med. Microbiol. 39, 233-238.
26. Creger, R.J., K.E. Weeman, M.R. Jacobs, A. Morrissey, P. Parker, R.M. Fox, and H.M. Lazarus. 1998. Lack of utility of the lysis-centrifugation blood culture method for detection of fungemia in immunocompromised cancer patients. J Clin. Microbiol. 36, 290-293.
27. Davey, K.G., P.M. Chant, C.S. Downer, C.K. Campbell, and D.W. Warnock. 1995. Evaluation of the AUXACOLOR system, a new method of clinical yeast identification. J Clin. Pathol. 48, 807-809.
28. th Annu. Meet. Am. Soc. Microbiol.
29. Denning, D.W., C.C. Kibbler, and R.A. Barnes. 2003. British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections. Lancet Infect. Dis. 3, 230-240.
30. De Repentigny, L., L.D. Marr, J.W. Keller, A.W. Carter, R.J. Kuykendall, L. Kaufman, and E. Reiss. 1985. Comparison of enzyme immunoassay and gas-liquid chromatography for the rapid diagnosis of invasive candidiasis in cancer patients. J Clin. Microbiol. 21, 972-979.
31. Doern, G.V., A. Barton, and S. Rao. 1998. Controlled comparative evaluation of BacT/Alert FAN and ESP 80A aerobic media as means for detecting bacteremia and fungemia. J Clin. Microbial. 36, 2686-2689.
32. Donnelly, S.M., D.J. Sullivan, D.B. Shanley, and D.C. Coleman. 1999. Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences. Microbiol. 145, 1871-1882.
33. Edmond, M.B., S.E. Wallace, D.K. McClish, M.A. Pfaller, R.N. Jones, and R.P. Wenzel. 1999. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin. Infect. Dis. 29, 239-244.
34. Edwards Jr, J.E. 1992. Should all patients with candidemia be treated with antifungal agents? Clin. Infect. Dis. 15, 4222-4223.
35. Einsele, H., H. Hebart, G. Roller, J. Loffler, I. Rothenhofer, C.A. Muller, R.A. Bowden, J. van Burik, D. Engelhard, L. Kanz, and U. Schumacher. 1997. Detection and identification of fungal pathogens in blood by using molecular probes. J Clin. Microbiol. 5, 1353-1360.
36. Elie, C.M., T.J. Lott, E. Reiss, and C.J. Morrison. 1998. Rapid identification of Candida species using species-specific DNA probes. J Clin. Microbiol. 36, 3260-3265.
37. Ellepola, A.N., S.F. Hurst, C.M. Elie, and C.J. Morrison. 2003. Rapid and unequivocal differentiation of Candida dubliniensis from other Candida species using species-specific DNA probes: comparison with phenotypic identification methods. Oral. Microbiol. Immunol. 18, 379-388.
38. El Moudni, B., M.H. Rodier, G. Daniault, and J.L. Jacquemin. 1998. Improved immunodiagnosis of human candidiasis by an enzyme-linked immunosorbent assay using a Candida albicans 52-kilodalton metallopeptidase. Clin. Diagn. Lab. Immunol. 5, 823-825.
39. Espinel-Ingroff, A., L. Stockman, G. Roberts, D. Pincus, J. Pollack, and J. Marler. 1998. Comparison of RapID Yeast Plus system with API 20C system for identification of common, new, and emerging yeast pathogens. J Clin. Microbiol. 36, 883-886.
40. Flahaut, M., D. Sanglard, M. Monod, J. Bille, and M. Rossier. 1998. Rapid detection of Candida albicans in clinical samples by DNA amplification of common regions from C. albicans-secreted aspartic proteinase genes. J Clin. Microbiol. 36, 395-401.
41. Freydiere, A.M. 1996. Evaluation of CHROMagar Candida plates. J Clin. Microbiol. 34, 2048.
42. Freydiere, A.M., L. Buchaille, and Y. Gille. 1997a. Comparison of three media for direct identification and discrimination of Candida species in clinical specimens. Eur. J Clin. Microbiol. Infect. Dis. 16, 464-467.
43. Freydiere, A.M., L. Buchaille, R. Guinet, and Y. Gille. 1997b. Evaluation of latex reagents for rapid identification of Candida albicans and C. krusei colonies. J Clin. Microbiol. 35, 877-880.
44. Freydiere, A.M., R. Guinet, and P. Boiron. 2001. Yeast identification in the clinical microbiology laboratory: phenotypical methods. Med. Mycol. 39, 9-33.
45. Fujita, S., F. Matsubara, and T. Matsuda. 1986. Enzyme-linked immunosorbent assay measurement of fluctuations in antibody titer and antigenemia in cancer patients with and without candidiasis. J Clin. Microbiol. 23, 568-575.
46. Fujita, S.I., B.A. Lasker, T.J. Lott, E. Reiss, and C.J. Morrison. 1995. Microtitration plate enzyme immunoassay to detect PCR-amplified DNA from Candida species in blood. J Clin. Microbiol. 33, 962-967.
47. Fujita, S.I. and T. Hashimoto. 1992. Detection of serum Candida antigens by enzyme-linked immunosorbent assay and a latex agglutination test with anti-Candida albicans and anti-Candida krusei antibodies. J Clin. Microbiol. 30, 3131-3137.
48. Fuller, D.D., T.E. Davis Jr, G.A. Denys, and M.K. York. 2001. Evaluation of BACTEC MYCO/F Lytic medium for recovery of mycobacteria, fungi, and bacteria from blood. J Clin. Microbiol. 39, 2933-2936.
49. Gentry, L.O., I.D. Wilkinson, A.S. Lea, and M.F. Price. 1983. Latex agglutination test for detection of Candida antigen in patients with disseminated disease. Eur J Clin. Microbiol. Infect. Dis. 3, 122-128.
50. Graf, B., A. Trost, J. Eucker, U.B. Gobel, and T. Adam. 2004. Rapid and simple differentiation of C. dubliniensis from C. albicans. Diagn. Microbiol. Infect. Dis. 48, 149-151.
51. Greenfield, R.A., M.J. Bussey, J.L Stephens, and J.M. Jones. 1983. Serial enzyme-linked immunosorbent assay for antibody to Candida antigens during induction chemotherapy for acute leukemia. J Infect. Dis. 148, 275-283.
52. Greenfield, R.A. and J.M. Jones. 1981. Purification and characterization of a major cytoplasmic antigen of Candida albicans. Infect. Immun. 34, 469-477.
53. Gudlaugsson, O., S. Gillespie, K. Lee, J. Vande Berg, J. Hu, S. Messer, L. Herwaldt, M. Pfaller, and D. Diekema. 2003. Attributable mortality of nosocomial candidemia, revisited. Clin. Infect Dis. 37, 1172-1177.
54. Guiver, M., K. Levi, and B.A. Oppenheim. 2001. Rapid identification of Candida species by TaqMan PCR. J Clin. Pathol. 54, 362-366.
55. Hajjeh, R.A., A.N. Sofair, L.H. Harrison, G.M. Lyon, B.A. Arthington-Skaggs, S.A. Mirza, M. Phelan, J. Morgan, W. Lee-Yang, M.A. Ciblak, L.E. Benjamin, L.T. Sanza, S. Huie, S.F. Yeo, M.E. Brandt, and D.W. Warnock. 2004. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin. Microbiol. 42, 1519-1527.
56. Hall, L., S. Wohlfiel, and G.D. Roberts. 2003. Experience with the MicroSeq D2 large-subunit ribosomal DNA sequencing kit for identification of commonly encountered, clinically important yeast species. J Clin. Microbiol. 41, 5099-5102.
57. Haynes, K.A., T.J. Westerneng, J.W. Fell, and W. Moens. 1995. Rapid detection and identification of pathogenic fungi by polymerase chain reaction amplification of large subunit ribosomal DNA. J Med. Vet. Mycol. 33, 319-325.
58. Heelan, J.S., E. Sotomayor, K. Coon, and J.B. D'Arezzo. 1998. Comparison of the rapid yeast plus panel with the API20C yeast system for the identification of clinically significant isolates of Candida species. J Clin. Microbiol. 36, 1443-1445.
59. Holmes, A.R., R.D. Cannon, M.G. Shepherd, and H.F. Jenkinson. 1994. Detection of Candida albicans and other yeasts in blood by PCR. J Clin. Microbiol. 32, 228-231.
60. Hopfer, R.L., P. Walden, S. Setterquist, and W.E. Highsmith. 1993. Detection and differentiation of fungi in clinical specimens using polymerase chain reaction (PCR) amplification and restriction enzyme analysis. J Med. Vet. Mycol. 31, 65-75.
61. Hoppe, J.E. and P. Frey. 1999. Evaluation of six commercial tests and the germ tube test for presumptive identification of Candida albicans. Eur. J Clin. Microbiol. Infect. Dis. 18, 188-191.
62. Horvath, L.L., B.J. George, C.K. Murray, L.S. Harrison, and D.R. Hospenthal. 2004. Direct comparison of the BACTEC 9240 and BacT/ALERT 3D automated blood culture systems for Candida growth detection. J Clin. Microbiol. 42, 115-118.
63. Hsu, M.C., K.W. Chen, H.J. Lo, Y.C. Chen, M.H. Liao, Y.H. Lin, and S.Y. Li. 2003. Species identification of medically important fungi by use of real-time LightCycler PCR. J Med. Microbiol. 52, 1071-1076.
64. Hube, B. 1996. Candida albicans secreted aspartyl proteinases. Curr. Top. Med. Mycol. 7, 55-69.
65. Hui, M., M. Ip, P.K. Chan, M.L. Chin, and A.F. Cheng. 2000. Rapid identification of medically important Candida to species level by polymerase chain reaction and single-strand conformational polymorphism. Diagn. Microbiol. Infect. Dis. 38, 95-99.
66. Irobi, J., A. Schoofs, and H. Goossens. 1999. Genetic identification of Candida species in HIV-positive patients using the polymerase chain reaction and restriction fragment length polymorphism analysis of its DNA. Mol. Cell. Probes. 13, 401-406.
67. Iwasaki, H., H. Misaki, T. Nakamura, and T. Ueda. 2000. Surveillance of the serum Candida antigen titer for initiation of antifungal therapy after post-remission chemotherapy in patients with acute leukemia. Intl. J Hematol. 71, 266-272.
68. Iwen, P.C., A.G. Freifeld, T.A. Bruening, and S.H. Hinrichs. 2004. Use of a panfungal PCR assay for detection of fungal pathogens in a commercial blood culture system. J Clin. Microbiol. 42, 2292-2293.
69. Jabra-Rizk, M.A., T.M. Brenner, M. Romagnoli, A.A. Baqui, W.G. Merz, W.A. Falkler Jr, and T.F. Meiller. 2001. Evaluation of a reformulated CHROMagar Candida. J Clin. Microbiol. 39, 2015-2016.
70. Jaeger, E.E., N.M. Carroll, S. Choudhury, A.A. Dunlop, H.M. Towler, M.M. Matheson, P. Adamson, N. Okhravi, and S. Lightman. 2000. Rapid detection and identification of Candida, Aspergillus, and Fusarium species in ocular samples using nested PCR. J Clin. Microbiol. 38, 2902-2908.
71. Jones, J.M. 1980a. Kinetics of antibody responses to cell wall mannan and a major cytoplasmic antigen of Candida albicans in rabbits and humans. J Lab. Clin. Med. 96, 845-860.
72. Jones, J.M. 1980b. Quantitation of antibody against cell wall mannan and a major cytoplasmic antigen of Candida in rabbits, mice, and humans. Infect. Immun. 30, 78-89.
73. Jordan, J. 1994. PCR identification of four medically important Candida species by using a single primer pair. J Clin. Microbiol. 32, 2962-2967.
74. Kahn, F.W. and J.M. Jones. 1986. Latex agglutination tests for detection of Candida antigens in sera of patients with invasive candidiasis. J Infect. Dis. 153, 579-585.
75. Kaufman, L., J.A. Kovacs, and E. Reiss. 1997. Clinical Immunomycology, p. 585-604. In N.R. Rose, E.C. de Macario, J.D. Folds, H.C. Lane, and R.M. Nakamura (eds.), Manual of Clinical Laboratory Immunology. ASM Press, Washington, D.C.
76. Kitch, T.T., M.R. Jacobs, M.R. McGinnis, and P.C. Appelbaum. 1996. Ability of RapID Yeast Plus System to identify 304 clinically significant yeasts within 5 hours. J Clin. Microbiol. 34, 1069-1071.
77. Kurtzman, C.P. and C.J. Robnett. 1997. Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5′ end of the large-subunit (26S) ribosomal DNA gene. J Clin. Microbiol. 35, 1216-1223.
78. Kurzai, O., W.J. Heinz, D.J. Sullivan, D.C. Coleman, M. Frosch, and F.A. Muhlschlegel. 1999. Rapid PCR test for discriminating between Candida albicans and Candida dubliniensis isolates using primers derived from the pH-regulated PHR1 and PHR2 genes of C. albicans. J Clin. Microbiol. 37, 1587-1590.
79. Kwok, S. and R. Higuchi. 1989. Avoiding false positives with PCR. Nature 339, 237-238.
80. Kwon-Chung, K.J., D. Lehman, C. Good, and P.T. McGee. 1985. Genetic evidence for role of extracellular proteinase in virulence of Candida albicans. Infect. Immun. 49, 571-575.
81. Land, G.A., I.F. Salkin, M. El-Zaatari, M.R. McGinnis, and G. Hashem. 1991. Evaluation of the Baxter MicroScan 4-hour enzyme-based yeast identification system. J Clin. Microbiol. 29, 718-722.
82. Lecciones, J.A., J.W. Lee, E.E. Navarro, F.G. Witebsky, D. Marshall, S.M. Steinberg, P.A. Pizzo, and T.J. Walsh. 1992. Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin. Infect. Dis. 14, 875-883.
83. Lemieux, C., G. St-Germain, J. Vincelette, L. Kaufman, and L. de Repentigny. 1990. Collaborative evaluation of antigen detection by a commercial latex agglutination test and enzyme immunoassay in the diagnosis of invasive candidiasis. J Clin. Microbiol. 28, 249-253.
84. Lischewski, A., M. Kretschman, H. Hof, R. Amann, J. Hacker, and J. Morschhauser. 1997. Detection and identification of Candida species in experimentally infected tissue and human blood by rRNA-specific fluorescent in situ hybridization. J Clin. Microbiol. 35, 2943-2948.
85. Loeffler, J., C. Dorn, H. Hebart, P. Cox, S. Magga, and H. Einsele. 2003. Development and evaluation of the nuclisens basic kit NASBA for the detection of RNA from Candida species frequently resistant to antifungal drugs. Diagn. Microbiol. Infect. Dis. 45, 217-220.
86. Loeffler, J., H. Hebart, S. Magga, D. Schmidt, L. Klingspor, J. Tollemar, U. Schumacher, and H. Einsele. 2000a. Identification of rare Candida species and other yeasts by polymerase chain reaction and slot blot hybridization. Diagn. Microbiol. Infect. Dis. 38, 207-212.
87. Loeffler, J., H. Hebart, S. Sepe, U. Schumacher, T. Klingbiel, and J. Einsele. 1998. Detection of PCR-amplified fungal DNA by using a PCR-ELISA system. Med. Mycol. 36, 275-279.
88. Loeffler, J., N. Henke, H. Hebart, D. Schmidt, L Hagmeyer, U. Schumacher, and H. Einsele H. 2000b. Quantification of fungal DNA by using fluorescence resonance energy transfer and the light cycler system. J Clin. Microbiol. 38, 586-590.
89. MacDonald, F. and F.C. Odds. 1983. Virulence for mice of a proteinase-secreting strain of Candida albicans and a proteinase-deficient mutant. J Gen. Microbiol. 129, 431-438.
90. Mannarelli, B.M. and C.P. Kurtzman. 1998. Rapid identification of Candida albicans and other human pathogenic yeasts by using short oligonucleotides in a PCR. J Clin. Microbiol. 36, 1634-1641.
91. Marcilla, A., C. Monteagudo, S. Mormeneo, and R. Sentandreu. 1999. Monoclonal antibody 3H8: a useful tool in the diagnosis of candidiasis. Microbiol. 145, 695-701.
92. Martin. C., D. Roberts, M. van Der Weide, R. Rossau, G. Jannes, T. Smith, and M. Maher. 2000. Development of a PCR-based line probe assay for identification of fungal pathogens. J Clin. Microbiol. 38, 3735-3742.
93. Mason, A.B., M.E. Brandt, and H.R. Buckley. 1989. Enolase activity associated with a Candida albicans cytoplasmic antigen. Yeast 5, S231-239.
94. Massonet, C., J. Van Eldere, M. Vaneechoutte, T. De Baere, J. Verhaegen, and K. Lagrou. 2004. Comparison of VITEK 2 with ITS2-fragment length polymorphism analysis for identification of yeast species. J Clin. Microbiol. 42, 2209-2211.
95. Matthews, R.J. and J.P. Burnie. 1988. Diagnosis of systemic candidiasis by an enzyme-linked dot immunobinding assay for a circulating immunodominant 47-kilodalton antigen. J Clin. Microbiol. 26, 459-463.
96. Matthews, R.J., J.P. Burnie, and S. Tabaqchali. 1987. Isolation of immunodominant antigens from sera of patients with systemic candidiasis and characterization of serological response to Candida albicans. J Clin. Microbiol. 25, 230-237.
97. McDonald, L.C., M.P. Weinstein, J. Fune, S. Mirrett, L.G. Reimer, and L.B. Reller. 2001. Controlled comparison of BacT/ALERT FAN aerobic medium and BACTEC fungal blood culture medium for detection of fungemia. J Clin. Microbiol. 39, 622-624.
98. Misaki, H., H. Iwasaki, and T. Ueda. 2003. A comparison of the specificity and sensitivity of two Candida antigen assay systems for the diagnosis of deep candidiasis in patients with hematologic diseases. Med. Sci. Monit. 9, MT1-7.
99. Miyakawa, Y., T. Mabuchi, and Y. Fukazawa. 1993. New method for detection of Candida albicans in human blood by polymerase chain reaction. J Clin. Microbiol. 31, 3344-3347.
100. Moghaddas, J., A.L. Truant, C. Jordan, and H.R. Buckley. 1999. Evaluation of the RapID Yeast Plus System for the identification of yeast. Diagn. Microbiol. Infect. Dis. 35, 271-273.
101. Morace, G., M. Sanguinetti, B. Posteraro, G. LoCascio, and G. Fadda. 1997. Identification of various medically important Candida species in clinical specimens by PCR-restriction enzyme analysis. J Clin. Microbiol. 35, 667-672.
102. Moran, G.P., D. Sanglard, S.M. Donnelly, D.B. Shanley, D.J. Sullivan, and D.C. Coleman. 1998. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis. Antimicrob. Agents Chemother. 42, 1819-1830.
103. Moran, G.P., D.J. Sullivan, M.C. Henman, C.E. McCreary, B.J. Harrington, D.B. Shanley, and D.C. Coleman. 1997. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob. Agents Chemother. 41, 617-623.
104. Morrison, C.J., S.F. Hurst, and E. Reiss. 2003. Competitive binding inhibition enzyme-linked immunosorbent assay that uses the secreted aspartyl proteinase of Candida albicans as an antigenic marker for diagnosis of disseminated candidiasis. Clin. Diagn. Lab. Immunol. 10, 835-848.
105. Na, B.K. and C.Y. Song. 1999. Use of monoclonal antibody in diagnosis of candidiasis caused by Candida albicans: detection of circulating aspartyl proteinase antigen. Clin. Diagn. Lab. Immunol. 6, 924-929.
106. Nguyen, M.H, J.E. Peacock Jr, A.J. Morris, D.C. Tanner, M.L. Nguyen, D.R. Snydman, M.M. Wagener, M.G. Rinaldi, and V.L. Yu. 1996. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med. 100, 617-623.
107. Obayashi, T., M. Yoshida, T. Mori, H. Goto, A. Yasuoka, H. Iwasaki, H. Teshima, S. Kohno, A. Horiuchi, and A. Ito. 1995. Plasma (1→3)-beta-D- glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet. 345, 17-20.
108. Obayashi, T., M. Yoshida, H. Tamura, J. Aketagawa, S. Tanaka, and Kawai T. 1992. Determination of plasma (1→3)-β-D-glucan: a new diagnostic aid to deep mycosis. J Med. Vet. Mycol. 30, 275-280.
109. nd ICAAC.
110. Odds, F. and R. Bernaerts. 1994. CHROMagar Candida, a new differential medium for presumptive identification of clinically important Candida species. J Clin. Microbiol. 12, 1923-1929.
111. Oliveira, K., G. Haase, C. Kurtzman, J.J. Hyldig-Nielsen, and H. Stender. 2001. Differentiation of Candida albicans and Candida dubliniensis by fluorescent in situ hybridization with peptide nucleic acid probes. J Clin. Microbiol. 39, 4138-4141.
112. Pallavicini, F., I. Izzi, M.A. Pennisi, G. Morace, G.G. Portaccio, G. Bello, F. Iodice, D. Godino, C. Del Borgo, and R. Proietti. 1999. Evaluation of the utility of serological tests in the diagnosis of candidemia. Minerva Anestesiologica. 65, 637-639.
113. Pappas, P.G., J.H. Rex, J.D. Sobel, S.G. Filler, W.E. Dismukes, T.J. Walsh, and J.E. Edwards. 2004. Guidelines for treatment of candidiasis. Clin. Infect. Dis. 15, 161-189.
114. Patterson, T.F., S.G. Revankar, W.R. Kirkpatrick, R.K. McAtee, A.W. Fothergill, D.I. McCarthy, and M.G. Rinaldi. 1996. Simple method for detecting fluconazole-resistant yeasts with chromogenic agar. J Clin. Microbiol. 34, 1794-1797.
115. Petti, C.A., A.K. Zaidi, S. Mirrett, and L.B. Reller. 1996. Comparison of Isolator 1.5 and BACTEC NR660 aerobic 6A blood culture systems for the detection of fungemia in children. J Clin. Microbiol. 34, 1877-1879.
116. Pfaller, M.A., A. Houston, and S. Coffmann. 1996. Application of CHROMagar Candida for rapid screening of clinical specimens for Candia albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata. J Clin. Microbiol. 34, 58-61.
117. Pfaller, M.A., S.A. Messer, S. Gee, S. Joly, C. Pujol, D.J. Sullivan, D.C. Coleman, and D.R. Soll. 1999. In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents. J Clin. Microbiol. 37, 870-872.
118. Phillips, P., A. Dowd, P. Jewesson, G. Radigan, M.G. Tweeddale, A. Clarke, I. Geere, and M. Kelly. 1990. Nonvalue of antigen detection immunoassays for diagnosis of candidemia. J Clin. Microbiol. 28, 2320-2326.
119. Posteraro, B., M. Sanguinetti, L. Masucci, L. Romano, G. Morace, and G. Fadda. 2000. Reverse cross blot hybridization assay for rapid detection of PCR-amplified DNA from Candida speceis, Cryptococcus neoformans, and Saccharomyces cerevisiae in clinical samples. J Clin. Microbiol. 38, 1609-1614.
120. Powell, H.L., C.A. Sand, and R.P. Rennie. 1998. Evaluation of CHROMagar Candida for presumptive identification of clinically important Candida species. Diagn. Microbiol. Infect Dis. 32, 201-204.
121. Price, M.F, M.T. LaRocco, and L.O. Gentry. 1994. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob. Agents Chemother. 38, 1422-1424.
122. Procop, G.W., F.R. Cockerill 3rd, E.A. Vetter, W.S. Harmsen, J.G. Hughes, and G.D. Roberts. 2000. Performance of five agar media for recovery of fungi from isolator blood cultures. J Clin. Microbiol. 38, 3827-3829.
123. Pryce, T.M., I.D. Kay, S. Palladino, and C.H. Heath. 2003. Real-time automated polymerase chain reaction (PCR) to detect Candida albicans and Aspergillus fumigatus DNA in whole blood from high-risk patients. Diagn. Microbiol. Infect Dis. 47, 487-496.
124. Quindos, G., R. San Millan, R. Robert, C. Bernard, and J. Poton. 1997. Evaluation of Bichro-latex albicans, a new method for rapid identification of Candida albicans. J Clin. Microbiol. 35, 1263-1265.
125. Quindos, G., V. Lipperheide, and J. Ponton. 1993. Evaluation of two commercialized systems for the rapid identification of medically important yeasts. Mycoses. 36, 299-303.
126. Rabkin, J.M., S.L. Oroloff, C.L. Corless, K.G. Benner, K.D. Flora, H.R. Rosen, and A.J. Olyaei. 2000. Association of fungal infection and increased mortality in liver transplant recipients. Am J Surg. 179, 426-430.
127. Rand, K.H., H. Houck, and M. Wolff. 1994. Detection of candidemia by polymerase chain reaction. Mol. Cell Probes. 8, 215-222.
128. Ray, T.L. and C.D. Payne. 1988. Scanning electron microscopy of epidermal adherence and cavitation in murine candidiasis: a role for Candida acid proteinase. Infect. Immun. 56, 1942-1949.
129. Ray, T.L., C.D. Payne, and B.J. Morrow. 1991. Candida acid proteinases: characterization and role in candidiasis. Adv. Exp. Med. Biol. 306, 173-183.
130. Rees, J.R., R.W. Pinner, R.A. Hajjeh, M.E. Brandt, and A.L. Reingold. 1998. The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance. Clin. Infect. Dis. 27, 1138-1147.
131. Reimer, L.G., M.L. Wilson, and M.P. Weinstein. 1997. Update on detection of bacteremia and fungemia. Clin. Microbiol. Rev. 10, 444-465.
132. Reiss, E. and C.J. Morrison. 1993. Nonculture methods for the diagnosis of Candida infections. Clin. Microbiol. Rev. 6, 311-323.
133. Rex JH, Bennett JE, Sugar AM, P.G. Pappas, C.M. van der Horst, J.E. Edwards, R.G. Washburn, W.M. Scheld, A.W. Karchmer, and A.P. Dine. 1994. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Eng. J Med. 331, 1325-1330.
134. Rigby, S., G.W. Procop, G. Haase, D. Wilson, G. Hall, C. Kurtzman, K. Oliveira, S. Von Oy, J.J. Hyldig-Nielsen, J. Coull, and H. Stender. 2002. Fluorescence in situ hybridization with peptide nucleic acid probes for rapid identification of Candida albicans directly from blood culture bottles. J Clin. Microbiol. 40, 2182-2186.
135. Ruchel, R. 1992 Proteinase, p. 17-33. In J.E. Bennett, R.J. Hay, and P.K. Peterson (eds.), New Strategies in Fungal Disease. Churchill-Livingstone, Edinburgh.
136. Ruchel, R. and B. Boning-Stutzer. 1983. Detection of Candida proteinase by enzyme immunoassay and interaction of the enzyme with alpha-2-macroglobulin. J Immunol. Methods. 61, 107-116.
137. Ruchel, R., B. Boning-Stutzer, and A. Mari. 1988. A synoptical approach to the diagnosis of candidosis, relying on serological antigen and antibody tests, on culture, and on evaluation of clinical data. Mycoses. 31, 87-106.
138. Saeki, F., R.J. Ridge, M.A. Finkelman, P.A. Ketchum, and J.H. Rex. 2001. Application of a glucan-specific limulus amebocyte lysate serum assay for diagnosis of invasive fungal infections. Abstr. J-841, p. 386. Abstr. 41st ICAAC.
139. Sandhu, G., B.C. Kline, L. Stockman, and G.D. Roberts. 1995. Molecular probes for diagnosis of fungal infections. J Clin. Microbiol. 33, 2913-2919.
140. San-Millan, R., L. Ribacoba, J. Ponton, and G. Quindos. 1996. Evaluation of a commercial medium for identification of Candida species. Eur. J Clin. Microbiol. Infect Dis. 15, 153-158.
141. Schmidt, D., J. Loeffler, H. Hebart, U. Schumacher, and H. Einsele. 2001. Rapid extraction and detection of DNA from Candida species in research samples by MagNA Pure LC and the light cycler. Biochemica. 3, 1-3.
142. Selvarangan, R., U. Bui, A.P. Limaye, and B.T. Cookson. 2003. Rapid identification of commonly encountered Candida species directly from blood culture bottles. J Clin. Microbiol. 41, 5660-5664.
143. Selvarangan, R., A.P. Limaye, and B.T. Cookson. 2002. Rapid identification and differentiation of Candida albicans and Candida dubliniensis by capillary-based amplification and fluorescent probe hybridization. J Clin. Microbiol. 40, 4308-4312.
144. Sendid, B., T. Jouault, R. Coudriau, D. Camus, F. Odds, M. Tabouret, and D. Poulain. 2004. Increased sensitivity of mannanemia detection tests by joint detection of α- and β-linked oligomannosides during experimental and human systemic candidiasis. J Clin. Microbiol. 42, 164-171.
145. Sendid, B., M. Tabouret, J.L. Poirot, D. Mathieu, J. Fruit, and D. Poulain. 1999. New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis. J Clin. Microbiol. 37, 1510-1517.
146. Shin, J.H., F.S. Nolte, and C.J. Morrison. 1997. Rapid identification of Candida species in blood cultures by a clinically useful PCR method. J Clin. Microbiol. 35, 1454-1459.
147. Shin, J.H., F.S. Nolte, and C.J. Morrison. 1999. Rapid identification of up to three Candida species in a single reaction tube by a 5′ exonuclease assay using fluorescent DNA probes. J Clin. Microbiol. 37, 165-170.
148. Staib, F. 1965. Serum-proteins as nitrogen source for yeast-like fungi.
149. Stevens, P., S. Huang, L.S. Young, and M. Berdischewsky. 1980. Detection of Candida antigenemia in human invasive candidiasis by a new solid phase radioimmunoassay. Infection. 8, S334-338.
150. St-Germain, G. and D. Beauchesne. 1991. Evaluation of the MicroScan rapid yeast identification panel. J Clin. Microbiol. 29, 2296-2299.
151. Strockbine, N.A., M.T. Largen, and H.R. Buckley. 1984a. Production and characterization of three monoclonal antibodies to Candida albicans proteins. Infect. Immun. 43, 1012-1018.
152. Strockbine, N.A., M.T. Largen, S.M. Zweibel, and H.R. Buckley. 1984b. Identification and molecular weight characterization of antigens from Candida albicans that are recognized by human sera. Infect. Immun. 43, 715-721.
153. Sundstrom, P. and G.R. Aliaga. 1992. Molecular cloning of cDNA and analysis of protein secondary structure of Candida albicans enolase, an abundant, immunodominant glycolytic enzyme. J Bacteriol. 174, 6789-6799.
154. Switchenko, A.C., C.G. Miyada, T.C. Goodman, T.J. Walsh, B. Wong, M.J. Becker, and E.F. Ullman. 1994. An automated enzymatic method for measurement of D-arabinitol, a metabolite of pathogenic Candida species. J Clin. Microbiol. 32, 92-97.
155. Takesue, Y., M. Kakehashi, H. Ohge, Y. Imamura, Y. Murakami, M. Sasaki, M. Morifuji, Y. Yokoyama, M. Kouyama, T. Yokoyama, and T. Sueda. 2004. Combined Assessment of β-d-Glucan and Degree of Candida Colonization before Starting Empiric Therapy for Candidiasis in Surgical Patients. World J Surg. In press.
156. Tamura, H., Y. Arimoto, S. Tanaka, M. Yoshida, T. Obayashi, and T. Kawai. 1994. Automated kinetic assay for endotoxin and (1→3)-β-D-glucan in human blood. Clin Chim Acta. 226, 109-112.
157. Tiraboschi, I.N., J.E. Bennett, C.A. Kaufmann, J.H. Rex, C. Girmenia, J.D. Sobel, and F. Menichetti. 2000. Deep Candida infections in the neutropenic and non-neutropenic host: an ISHAM symposium. Med. Mycol. 38, 199-204.
158. Trick, W.E., S.K. Fridkin, J.R. Edwards, R.A. Hajjeh, and R.P. Gaynes. 2002. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin. Infect. Dis. 35, 627-630.
159. van Deventer, A.J., W.H. Goessens, A. van Belkum, H.J. van Vliet, E.W. van Etten, and H.A. Verbrugh. 1995. Improved detection of Candida albicans by PCR in blood of neutropenic mice with systemic candidiasis. J Clin. Microbiol. 33, 625-628.
160. Verduyn Lunel, F.M., A. Voss, E.J. Kuijper, L.B. Gelinck, P.M. Hoogerbrugge, K.L. Liem, B.J. Kullberg, and P.E. Verweij. 2004. Detection of the Candida antigen mannan in cerebrospinal fluid specimens from patients suspected of having Candida meningitis. J Clin. Microbiol. 42, 867-870.
161. Verghese, S.L., P. Padmaja, P. Sutha, T. Mathew, and E.S. John. 2000. Rapid identification of fluconazole resistance using CHROMagar Candida. Ind. J Pathol. Microbiol. 43, 343-346.
162. Verweij, P.E., I.M. Breuker, A.J. Rijs, and J.F. Meis. 1999. Comparative study of seven commercial yeast identification systems. J Clin. Pathol. 52, 271-273.
163. Vetter, E., C. Torgerson, A. Feuker, J. Hughes, S. Harmsen, C. Schleck, C. Horstmeier, G. Roberts, and F. Cockerill 3rd. 2001. Comparison of the BACTEC MYCO/F Lytic bottle to the isolator tube, BACTEC Plus Aerobic F/bottle, and BACTEC Anaerobic Lytic/10 bottle and comparison of the BACTEC Plus Aerobic F/bottle to the Isolator tube for recovery of bacteria, mycobacteria, and fungi from blood. J Clin. Microbiol. 39, 4380-4386.
164. Wadlin, J.K., G. Hanko, R. Stewart, J. Pape, and I. Nachamkin. 1999. Comparison of three commercial systems for identification of yeasts commonly isolated in the clinical microbiology laboratory. J Clin. Microbiol. 37, 1967-1970.
165. Walsh, T.J. and S.J. Chanock. 1998. Diagnosis of invasive fungal infections: advances in nonculture systems. Curr. Clin. Top Infect. Dis. 18, 101-153.
166. Walsh, T.J., A. Francesconi, M. Kasai, and S.J. Chanock. 1995a. PCR and single-strand conformational polymorphism for recognition of medically important opportunistic fungi. J Clin. Microbiol. 33, 3216-3220.
167. Walsh, T.J., J.W. Hathorn, J.D. Sobel, W.G. Merz, V. Sanchez, S.M. Maret, H.R. Buckley, M.A. Pfaller, R. Schaufele, and C. Sliva. 1991. Detection of circulating Candida enolase by immunoassay in patients with cancer and invasive candidiasis. N Eng J Med. 324, 1026-1031.
168. Walsh, T.J., J.W. Lee, T. Sein, R. Schaufele, J. Bacher, A.C. Switchenko, T.C. Goodman, and P.A. Pizzo. 1994. Serum D-arabinitol measured by automated quantitative enzymatic assay for detection and therapeutic monitoring of experimental disseminated candidiasis: correlation with tissue concentrations of Candida albicans. J Med. Vet. Mycol. 32, 205-215.
169. Walsh, T.J., W.G. Merz, J.W. Lee, R. Schaufele, T. Sein, P.O. Whitcomb, M. Ruddel, W. Burns, J.R. Wingard, and A.C. Switchenko. 1995b. Diagnosis and therapeutic monitoring of invasive candidiasis by rapid enzymatic detection of serum D-arabinitol. Am J Med. 99, 164-172.
170. Washington, J.A. 1994. Collection, transport, and processing of blood cultures. Clin Lab. Med. 14, 59-68.
171. Wildfeuer, A., R. Schlenk, and W. Friedrich. 1996. Detection of Candida albicans DNA with a yeast-specific primer system by polymerase chain reaction. Mycoses. 39, 341-346.
172. Willinger, B. and M. Manafi. 1999. Evaluation of CHROMagar Candida for rapid screening of clinical specimens for Candida species. Mycoses. 42, 61-65.
173. Wingard, J.R. 1995. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin. Infect. Dis. 20, 115-125.
174. Wong, B., E.M. Bernard, J.W. Gold, D. Fong, and D. Armstrong. 1982. The arabinitol appearance rate in laboratory animals and humans: estimation from the arabinitol/creatinine ratio and relevance to the diagnosis of candidiasis. J Infect. Dis. 146, 353-359.
175. Wong, B., K.L. Brauer, J.R. Clemons, and S. Beggs. 1990. Effects of gastrointestinal candidiasis, antibiotics, dietary arabinitol, and cortisone acetate on levels of the Candida metabolite D-arabinitol in rat serum and urine. Infect. Immun. 58, 283-288.
176. Yeo, S.F., Y. Zhang, D. Schafer, S. Campbell, and B. Wong. 2000. A rapid, automated enzymatic fluorometric assay for determination of D-arabinitol in serum. J Clin. Microbiol. 38, 1439-1443.
177. Yera, H., B. Sendid, N. Francois, D. Camus, and D. Poulain. 2001. Contribution of serological tests and blood culture to the early diagnosis of systemic candidiasis. Eur. J Clin. Microbiol. Infect. Dis. 20, 864-870.
178. Yoshida, M., T. Obayashi, A. Iwama, M. Ito, S. Tsunoda, T. Suzuki, K. Muroi, M. Ohta, S. Sakamoto, and Y. Miura. 1997. Detection of plasma (1→3)-β-D-glucan in patients with Fusarium, Trichosporon, Saccharomyces and Acremonium fungaemias. J Med. Vet. Mycol. 35, 371-374.